Digital EpiPen injection: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Accidental digital self-injection of epinephrine from an EpiPen. | *Accidental digital self-injection of epinephrine from an EpiPen. | ||
==Clinical Features== | |||
*Puncture wound with delayed capillary refill (vasoconstriction) | |||
==Differential Diagnosis== | |||
==Evaluation== | ==Evaluation== | ||
* | *Typically a clinical diagnosis (no testing required) | ||
==Treatment== | ==Treatment== | ||
| Line 12: | Line 15: | ||
</ref> | </ref> | ||
*If continued ischemia symptoms after 2 hrs | *If continued ischemia symptoms after 2 hrs | ||
**give phentolamine mesylate 1.5mg in 1 mL of lidocaine into the ischemic area | **give [[phentolamine]] mesylate 1.5mg in 1 mL of [[lidocaine]] into the ischemic area | ||
==Disposition== | ==Disposition== | ||
* | *Outpatient | ||
==See Also== | ==See Also== | ||
Revision as of 07:12, 12 March 2017
Background
- Accidental digital self-injection of epinephrine from an EpiPen.
Clinical Features
- Puncture wound with delayed capillary refill (vasoconstriction)
Differential Diagnosis
Evaluation
- Typically a clinical diagnosis (no testing required)
Treatment
- Observation for 2 hours after injection[1]
- If continued ischemia symptoms after 2 hrs
- give phentolamine mesylate 1.5mg in 1 mL of lidocaine into the ischemic area
Disposition
- Outpatient
See Also
References
- ↑ "Six Years of Epinephrine Digital injections: Absence of Significant Local or Systemic Effects." Annals of EM. Sept. 2010. 56(3):p270-274.